# Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty

> **NCT05518513** · NA · UNKNOWN · sponsor: **National Cheng-Kung University Hospital** · enrollment: 66 (estimated)

## Conditions studied

- Arthroplasty, Replacement, Knee
- Adductor Canal Block

## Interventions

- **DRUG:** Bupivacain

## Key facts

- **NCT ID:** NCT05518513
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2024-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05518513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05518513, "Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05518513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*